Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- No Sleep Till Activism: Hedge Fund H Partners Wins Mattress Company Fight also written by Antoine Gara
Login to comment.